Key result
Everolimus-eluting stent implantation in pigs enhanced coronary vasoconstricting responses to serotonin at the stent edges compared with nonstented control sites.
Why the study?
Does everolimus-eluting stent implantation induce coronary perivascular adipose tissue inflammation and hyperconstricting responses in a porcine model?
RCT (n=40)
randomly implanted
Does everolimus-eluting stent implantation induce coronary perivascular adipose tissue inflammation and hyperconstricting responses in a porcine model?
Everolimus-eluting stents induce coronary perivascular adipose tissue inflammation and hyperconstricting responses in pigs, which can be assessed using 18F-FDG PET imaging.
Answers are grounded in this paper and cite their sources.
Animal results are hypothesis-generating for everolimus-eluting stent edge effects; human studies needed to assess relevance.
Objective— Although coronary perivascular adipose tissue (PVAT) may play important roles as a source of inflammation, the association of coronary PVAT inflammation and coronary hyperconstricting responses remains to be examined. We addressed this important issue in a porcine model of coronary hyperconstricting responses after drug-eluting stent implantation with 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomographic imaging. Approach and Results— An everolimus-eluting stent (EES) was randomly implanted in pigs into the left anterior descending or the left circumflex coronary artery while nonstented coronary artery was used as a control. After 1 month, coronary vasoconstricting responses to intracoronary serotonin (10 and 100 μg/kg) were examined by coronary angiography in vivo, followed by in vivo and ex vivo 18 F-FDG positron emission tomographic/computed tomographic imaging. Coronary vasoconstricting responses to serotonin were significantly enhanced at the EES edges compared with the control site ( P <0.01; n=40). Notably, in vivo and ex vivo 18 F-FDG positron emission tomographic/computed tomographic imaging and autoradiography showed enhanced 18 F-FDG uptake and its accumulation in PVAT at the EES edges compared with the control site, respectively (both P <0.05). Furthermore, histological and reverse transcription polymerase chain reaction analysis showed that inflammatory changes of coronary PVAT were significantly enhanced at the EES edges compared with the control site (all P <0.01). Importantly, Rho-kinase expressions (ROCK1/ROCK2) and Rho-kinase activity (phosphorylated myosin phosphatase target subunit-1) at the EES edges were significantly enhanced compared with the control site. Conclusions— These results indicate for the first time that inflammatory changes of coronary PVAT are associated with drug-eluting stent–induced coronary hyperconstricting responses in pigs in vivo and that 18 F-FDG positron emission tomographic imaging is useful for assessment of coronary PVAT inflammation.
No takes yet. Share an insight, caveat, or question.
Ohyama et al. (2017) conducted an RCT in Coronary hyperconstricting responses after drug-eluting stent implantation (n=40). Everolimus-eluting stent (EES) vs. Nonstented coronary artery was evaluated on Coronary vasoconstricting responses to intracoronary serotonin (p=<0.01). Everolimus-eluting stent implantation in pigs enhanced coronary vasoconstricting responses to serotonin at the stent edges compared with nonstented control sites.
Synapse has enriched 10 related papers. Consider them for comparative context: